H.R.5651 - Food and Drug Administration Reform Act of 2012

To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. view all titles (11)

All Bill Titles

  • Official: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
  • Short: Food and Drug Administration Reform Act of 2012 as passed house.
  • Short: Biosimilar User Fee Act of 2012 as passed house.
  • Short: Generic Drug User Fee Amendments of 2012 as passed house.
  • Short: Medical Device User Fee Amendments of 2012 as passed house.
  • Short: Prescription Drug User Fee Amendments of 2012 as passed house.
  • Short: Food and Drug Administration Reform Act of 2012 as introduced.
  • Short: Biosimilar User Fee Act of 2012 as introduced.
  • Short: Generic Drug User Fee Amendments of 2012 as introduced.
  • Short: Medical Device User Fee Amendments of 2012 as introduced.
  • Short: Prescription Drug User Fee Amendments of 2012 as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.


All Votes

Result: Passed - May 30, 2012

Roll call number 294 in the House

Question: On Motion to Suspend the Rules and Pass, as Amended: H R 5651 Prescription Drug User Fee Amendments of 2012

 

Vote on This Bill

25% Users Support Bill

1 in favor / 3 opposed
 

Send Your Rep a Letter

about this bill Support Oppose Tracking
Track with MyOC

Top-Rated Comments